Mesa Laboratories, Inc.
MLAB
$61.66
-$1.43-2.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.01M | 29.07M | 32.29M | 26.00M | 29.99M |
| Total Receivables | 39.07M | 41.97M | 38.65M | 40.23M | 35.57M |
| Inventory | 28.11M | 25.37M | 28.12M | 29.74M | 31.77M |
| Prepaid Expenses | 4.30M | 2.36M | 3.25M | 3.67M | 3.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.77M | 3.91M | 8.53M | 8.33M | 5.44M |
| Total Current Assets | 98.26M | 102.69M | 110.85M | 107.98M | 106.69M |
|
|
|||||
| Total Current Assets | 98.26M | 102.69M | 110.85M | 107.98M | 106.69M |
| Net Property, Plant & Equipment | 31.69M | 48.72M | 31.60M | 32.07M | 31.40M |
| Long-term Investments | 188.05M | 181.76M | 177.15M | 183.75M | 179.72M |
| Goodwill | 188.05M | 181.76M | 177.15M | 183.75M | 179.72M |
| Total Other Intangibles | 97.40M | 96.88M | 98.18M | 108.82M | 109.46M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.34M | 3.31M | 19.37M | 21.47M | 13.09M |
| Total Assets | 435.74M | 433.35M | 437.15M | 454.10M | 440.36M |
|
|
|||||
| Total Accounts Payable | 6.27M | 5.75M | 4.09M | 5.99M | 5.66M |
| Total Accrued Expenses | 20.33M | 27.46M | 21.84M | 17.29M | 16.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 105.40M | 104.57M | 104.45M | 104.27M | 6.69M |
| Total Finance Division Other Current Liabilities | 17.50M | 26.18M | 25.50M | 25.69M | 25.59M |
| Total Other Current Liabilities | 17.50M | 26.18M | 25.50M | 25.69M | 25.59M |
| Total Current Liabilities | 149.49M | 163.96M | 155.88M | 153.23M | 54.87M |
|
|
|||||
| Total Current Liabilities | 149.49M | 163.96M | 155.88M | 153.23M | 54.87M |
| Long-Term Debt | 79.53M | 76.90M | 94.80M | 104.20M | 208.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 12.38M | 12.36M | 14.39M | 6.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.22M | 20.27M | 18.89M | 20.83M | 19.97M |
| Total Liabilities | 263.25M | 273.52M | 281.93M | 292.65M | 289.63M |
|
|
|||||
| Common Stock & APIC | 361.36M | 358.54M | 352.79M | 349.53M | 346.00M |
| Retained Earnings | -185.07M | -188.94M | -180.95M | -178.41M | -180.97M |
| Treasury Stock & Other | -3.80M | -9.78M | -16.62M | -9.67M | -14.30M |
| Total Common Equity | 172.50M | 159.83M | 155.21M | 161.45M | 150.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 172.50M | 159.83M | 155.21M | 161.45M | 150.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 172.50M | 159.83M | 155.21M | 161.45M | 150.73M |
|
|
|||||